Pharmacologic Therapy for Heart Failure with Preserved Ejection Fraction

被引:4
|
作者
Peters, Anthony E. [1 ,2 ]
DeVore, Adam D. [1 ,2 ]
机构
[1] Duke Univ, Med Ctr, Sch Med, Div Cardiol, 200 Trent Dr,4th Floor,Room 4225, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Duke Clin Res Inst, 200 Trent Dr,4th Floor,Room 4225, Durham, NC 27710 USA
关键词
Heart failure with preserved ejection fraction; Pharmacologic therapy; State-of-the-art; ATRIAL-FIBRILLATION; EXERCISE CAPACITY; DIASTOLIC DYSFUNCTION; OLDER PATIENTS; HEMODYNAMICS; HF; ALDOSTERONE; MANAGEMENT; PRESSURE; NITRITE;
D O I
10.1016/j.ccl.2022.06.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The pharmacologic management of HFpEF is an evolving field. Symptomatic management with diuretics and optimization of comorbidities remain important components of therapy. Therapies such as ARB, ACEi, ARNI, MRA, and SGLT-2I have been shown to reduce HF hospitalization risk, particularly in lower ranges of LVEF within HFpEF. Ongoing trials and investigations of emerging agents have the potential to further inform the optimal medical regimen for patients with HFpEF.
引用
收藏
页码:473 / 489
页数:17
相关论文
共 50 条
  • [1] Pharmacologic Management of Heart Failure with Preserved Ejection Fraction
    Huang, Dana
    Cheng, Judy W. M.
    [J]. ANNALS OF PHARMACOTHERAPY, 2010, 44 (12) : 1933 - 1945
  • [2] Current Status of Pharmacologic and Nonpharmacologic Therapy in Heart Failure with Preserved Ejection Fraction
    Kim, Mi-Na
    Park, Seong-Mi
    [J]. HEART FAILURE CLINICS, 2021, 17 (03) : 463 - 482
  • [3] Pharmacologic Heart Rate Modulation in Heart Failure With Preserved Ejection Fraction
    Eynde, Jef Van den
    Schuermans, Art
    Honigberg, Michael C.
    De Bruaene, Alexander Van
    Verbrugge, Frederik H.
    [J]. JACC-HEART FAILURE, 2023, 11 (08) : 1032 - 1033
  • [4] MEDICAL THERAPY FOR HEART FAILURE WITH PRESERVED EJECTION FRACTION
    Kjeldsen, Sverre Erik
    [J]. JOURNAL OF HYPERTENSION, 2023, 41 : E69 - E69
  • [5] Cell Therapy in Heart Failure with Preserved Ejection Fraction
    Frljak, Sabina
    Poglajen, Gregor
    Vrtovec, Bojan
    [J]. CARDIAC FAILURE REVIEW, 2022, 8
  • [6] Device Therapy for Heart Failure with Preserved Ejection Fraction
    Salah, Husam M.
    Levin, Allison P.
    Fudim, Marat
    [J]. CARDIOLOGY CLINICS, 2022, 40 (04) : 507 - 515
  • [7] Heart failure with preserved ejection fraction
    不详
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2024, 10 (01):
  • [8] Heart failure with preserved ejection fraction
    Arias, Miguel A.
    Alonso-Fernandez, Alberto
    Garcia-Rio, Francisco
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (17): : 1828 - 1829
  • [9] Heart Failure with Preserved Ejection Fraction
    Meyer, Adam
    Kerrigan, Martin
    [J]. HOSPITAL MEDICINE CLINICS, 2015, 4 (03) : 283 - 296
  • [10] Heart Failure with Preserved Ejection Fraction
    Gladden, James D.
    Chaanine, Antoine H.
    Redfield, Margaret M.
    [J]. ANNUAL REVIEW OF MEDICINE, VOL 69, 2018, 69 : 65 - 79